Healthcare
·
Biotechnology
RPRX rose 3.1% in a down week for Healthcare and sits just 2.1% below its 52-week high, but volume at 0.7x the 13-week average keeps confirmation less than emphatic.
Healthcare
·
Biotechnology
JAZZ closed just 1.2% below its 52-week high after a 26.0% quarter, but the latest advance came on only 0.7x normal volume and activity pressure has cooled from June levels.
Healthcare
·
Biotechnology
ROIV added 2.4% for the week and remains within 2.8% of its 52-week high, with biotechnology breadth supportive but volume confirmation still measured.
Healthcare
·
Biotechnology
RVMD remains in an active weekly Trend Signal and close to its 52-week peak, but the latest pullback came with participation at just 0.5x the 13-week average.
Healthcare
·
Biotechnology
BBIO rose 11.3% in the latest week and now sits 19.3% above its weekly Trend Line, with participation twice its 13-week norm. The caution is that Sharemaestro’s Trend Signal remains inactive and the stock is trading at a large premium to co
Healthcare
·
Biotechnology
VRTX added 7.5% in the latest week and closed just 0.2% below its 52-week high, but the Sharemaestro read remains balanced because the weekly Trend Signal is still inactive and participation has returned to baseline.
Healthcare
·
Biotechnology
The ADR gained 5.9% in the latest week and sits just 1.5% below its 52-week high, but the move lacks volume confirmation and carries a stretched premium to Sharemaestro Fair Value.
Healthcare
·
Biotechnology
Ascendis Pharma closed at $274.50, only 0.1% below its 52-week high, after a four-week advance of 30.4%. The Trend backdrop remains active, but lighter volume and a wide Fair Value premium keep the weekly read balanced rather than emphatic.
Healthcare
·
Biotechnology
EXEL added 5.5% for the week on 18.2M shares, keeping its 13-week Trend Signal active, but the move comes with valuation distance and a neutral expectancy read.
Healthcare
·
Biotechnology
INCY rallied 15.8% for the week and closed at $113.8, only 1.6% below its 52-week high, but the weekly Trend Signal remains inactive and Fair Value distance is stretched.
Healthcare
·
Biotechnology
AXSM slipped 1.8% for the week but remains only 3.7% below its 52-week high, leaving a constructive trend intact while confirmation has become less forceful.
Healthcare
·
Biotechnology
RPRX remains in an active weekly Trend Signal and sits 15.4% above its Trend Line, but a 3.5% weekly fall, fading pressure and average volume leave the latest read more balanced than bullish.
Healthcare
·
Biotechnology
JAZZ has cooled from a near-high run, with volume and Market Dynamics no longer confirming the earlier advance even as the weekly trend remains constructive.
Healthcare
·
Biotechnology
MRNA closed at 63.96 after a sharp weekly advance, ranking first in US Healthcare and US Biotechnology, but the Sharemaestro read remains balanced as activity pressure stays negative.
Healthcare
·
Biotechnology
ROIV ended the week at $31.43, only 4.2% below its 52-week high, but the latest move came on 0.9x average volume and a negative activity-pressure read.